University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) is a clinical research site located in Birmingham, Alabama, United States 35233.
Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Colorectal Cancer, Metastatic Pancreatic Ductal Adenocarcinoma, Peripheral T Cell Lymphoma.
Sponsors: Erasca, Inc., Affimed GmbH, CatalYm GmbH.
Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) has 3 clinical trials on record, with 1 currently active. Their work covers Metastatic Colorectal Cancer, Metastatic Pancreatic Ductal Adenocarcinoma, Peripheral T Cell Lymphoma.
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.